SCHEMBL6556795

SCHEMBL6556795

CCOc1cc(Cc2cnc(N)nc2N)cc(OCC)c1-c1cccc(NS(C)(=O)=O)c1

nearest known ligand 0.55

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DHFR P00374 5/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6555280 0.89 DHFR (0.54) DHFR
SCHEMBL6555799 0.86 DHFR (0.54) DHFR
SCHEMBL6555766 0.86 DHFR (0.52) DHFR
SCHEMBL6555143 0.84 DHFR (0.52) DHFR
SCHEMBL6555538 0.84 DHFR (0.60) DHFR
SCHEMBL6555409 0.82 DHFR (0.64) DHFR
SCHEMBL6873198 0.82 DHFR (0.52) DHFR
SCHEMBL6557326 0.82 DHFR (0.61) DHFR
SCHEMBL6555242 0.81 DHFR (0.55) DHFR
SCHEMBL6557526 0.81 DHFR (0.66) DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1230224-B1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2004-12-29 EP disclosed
US-6821980-B1 Substituted 5-benzyl-2,4-diaminopyrimidines BASILEA PHARMACEUTICA AG (CH) 2004-11-23 US disclosed
EP-1230224-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES F. HOFFMANN-LA ROCHE AG (CH) 2002-08-14 EP disclosed
WO-2001032633-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2001-05-10 WO disclosed